Zealand Pharma will soon launch first drug

Analyst estimates that Zealand Pharma's recently approved rescue pen Zegalogue can generate billion-kroner income for the Danish biotech company, which is getting ready to take the treatment to market.
Zealand Pharma President & CEO Emmanuel Dulac | Photo: Stine Bidstrup/ERH
Zealand Pharma President & CEO Emmanuel Dulac | Photo: Stine Bidstrup/ERH
BY RITZAU FINANS, TRANSLATED BY NIELSINE NIELSEN

It won't be long before Zealand Pharma sends a drug on the market for the first time. Analysts deem that this might generate a billion-kroner income, according to Danish newspaper Børsen.

Already a subscriber?Log in here

Read the whole article

Get access for 14 days for free. No credit card is needed, and you will not be automatically signed up for a paid subscription after the free trial.

With your free trial you get:

  • Access all locked articles
  • Receive our daily newsletters
  • Access our app
!
!
Must contain at least 6 characters
!
Must contain at least 2 characters
!
Must contain at least 2 characters

Get full access for you and your coworkers

Start a free company trial today

Share article

Sign up for our newsletter

Stay ahead of development by receiving our newsletter on the latest sector knowledge.

!
Newsletter terms

Front page now

Further reading